Long-term swallow outcomes and factors affecting swallowing dysfunction and quality of life among oral cancer patients: a prospective observational study.

Oral cancer Patient-reported outcomes Quality of life Swallowing dysfunction Sydney Swallow questionnaire Trismus Xerostomia

Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 09 05 2023
accepted: 25 07 2023
pubmed: 7 8 2023
medline: 7 8 2023
entrez: 7 8 2023
Statut: ppublish

Résumé

Oral cancer is one of the most common cancers among the Indian population. India bears the most burden of oral cancer globally. Impairment of swallowing function is often seen after treatment for oral cancer. The oral phase of swallowing is disrupted in patients undergoing resection for oral cancer. The primary purpose of this study was to evaluate the long-term swallowing outcomes of oral cancer patients using a patient-reported outcome questionnaire. All consecutive oral cancer patients in the cT2-T4 category undergoing curative-intent surgery and reconstruction at our institute from March 2020 to March 2022 were included in the study. The Sydney Swallow questionnaire (SSQ) and functional oral intake scale (FOIS) assessed swallowing outcomes six months after definitive treatment. WHO BREF quality-of-life questionnaire was used to assess health-related quality of life. A total of seventy patients with oral cancer were included. The median age was 49 years. The majority of them were males (90%). Tumors with cT4 constituted 62%; the rest, 48%, were cT2 and cT3 categories. The bulk of them were buccoalveolar tumors (64.3%. Almost two-thirds of the patients received multimodal treatment. Trismus and xerostomia were at 46% and 88%, respectively. The mean SSQ score was 257.4 ± 99.1. Swallowing outcomes are affected by T stage (p = 0.01), extent of resection (p = 0.01), multimodality treatment (p < 0.01), trismus (p = 0.05), and xerostomia (p = 0.01). Almost 69% of them required special food preparation for swallowing (FOIS 4&5). Patients with buccoalveolar disease (p = 0.05) had significantly poor quality of life. An advanced stage with extensive resection and receiving multimodal treatment has adverse swallowing outcomes. Post-treatment trismus and xerostomia also significantly affected swallowing results.

Sections du résumé

BACKGROUND BACKGROUND
Oral cancer is one of the most common cancers among the Indian population. India bears the most burden of oral cancer globally. Impairment of swallowing function is often seen after treatment for oral cancer. The oral phase of swallowing is disrupted in patients undergoing resection for oral cancer. The primary purpose of this study was to evaluate the long-term swallowing outcomes of oral cancer patients using a patient-reported outcome questionnaire.
METHODOLOGY METHODS
All consecutive oral cancer patients in the cT2-T4 category undergoing curative-intent surgery and reconstruction at our institute from March 2020 to March 2022 were included in the study. The Sydney Swallow questionnaire (SSQ) and functional oral intake scale (FOIS) assessed swallowing outcomes six months after definitive treatment. WHO BREF quality-of-life questionnaire was used to assess health-related quality of life.
RESULTS RESULTS
A total of seventy patients with oral cancer were included. The median age was 49 years. The majority of them were males (90%). Tumors with cT4 constituted 62%; the rest, 48%, were cT2 and cT3 categories. The bulk of them were buccoalveolar tumors (64.3%. Almost two-thirds of the patients received multimodal treatment. Trismus and xerostomia were at 46% and 88%, respectively. The mean SSQ score was 257.4 ± 99.1. Swallowing outcomes are affected by T stage (p = 0.01), extent of resection (p = 0.01), multimodality treatment (p < 0.01), trismus (p = 0.05), and xerostomia (p = 0.01). Almost 69% of them required special food preparation for swallowing (FOIS 4&5). Patients with buccoalveolar disease (p = 0.05) had significantly poor quality of life.
CONCLUSION CONCLUSIONS
An advanced stage with extensive resection and receiving multimodal treatment has adverse swallowing outcomes. Post-treatment trismus and xerostomia also significantly affected swallowing results.

Identifiants

pubmed: 37548702
doi: 10.1007/s00405-023-08155-x
pii: 10.1007/s00405-023-08155-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5091-5100

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Global Cancer Observatory. Available from: https://gco.iarc.fr/
Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM et al (2020) Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw JNCCN 18(7):873–898
doi: 10.6004/jnccn.2020.0031 pubmed: 32634781
Ekberg O, Hillarp B (1986) Radiologic evaluation of the oral stage of swallowing. Acta Radiol Diagn (Stockh) 27(5):533–537
doi: 10.1177/028418518602700508 pubmed: 3799224
LaBlance GR, Kraus K, Steckol KF (1991) Rehabilitation of swallowing and communication following glossectomy. Rehabil Nurs Off J Assoc Rehabil Nurses 16(5):266–270
Pauloski BR, Rademaker AW, Logemann JA, Colangelo LA (1998) Speech and swallowing in irradiated and nonirradiated postsurgical oral cancer patients. Otolaryngol-Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg 118(5):616–624
Watters AL, Cope S, Keller MN, Padilla M, Enciso R (2019) Prevalence of trismus in patients with head and neck cancer: a systematic review with meta-analysis. Head Neck 41(9):3408–3421
doi: 10.1002/hed.25836 pubmed: 31215723
Pauli N, Johnson J, Finizia C, Andréll P (2013) The incidence of trismus and long-term impact on health-related quality of life in patients with head and neck cancer. Acta Oncol Stockh Swed 52(6):1137–1145
doi: 10.3109/0284186X.2012.744466
Franzén L, Funegård U, Ericson T, Henriksson R (1992) Parotid gland function during and following radiotherapy of malignancies in the head and neck A consecutive study of salivary flow and patient discomfort. Eur J Cancer Oxf Engl 1990 28(2–3):457–462
Dwivedi RC, St Rose S, Roe JW, Khan AS, Pepper C, Nutting CM, Clarke PM, Kerawala CJ, Rhys-Evans PH, Harrington KJ, Kazi R (2010) Validation of the Sydney Swallow Questionnaire (SSQ) in a cohort of head and neck cancer patients. Oral Oncol 46(4):e10–e14. https://doi.org/10.1016/j.oraloncology.2010.02.004 . (Epub 2010 Mar 9)
doi: 10.1016/j.oraloncology.2010.02.004 pubmed: 20219415
Crary MA, Mann GD, Groher ME (2005) Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil 86(8):1516–1520. https://doi.org/10.1016/j.apmr.2004.11.049
doi: 10.1016/j.apmr.2004.11.049 pubmed: 16084801
van der Geer SJ, van Rijn PV, Kamstra JI et al (2019) Criterion for trismus in head and neck cancer patients: a verification study. Support Care Cancer 27:1129–1137. https://doi.org/10.1007/s00520-018-4402-z
doi: 10.1007/s00520-018-4402-z pubmed: 30109487
Jager DHJ, Bots CP, Forouzanfar T, Brand HS (2018) Clinical oral dryness score: evaluation of a new screening method for oral dryness. Odontology 106(4):439–444. https://doi.org/10.1007/s10266-018-0339-4 . (Epub 2018 Jan 22)
doi: 10.1007/s10266-018-0339-4 pubmed: 29356914 pmcid: 6153998
Pereira LJ, Braga Caputo J, Midori Castelo P, Francelino Andrade E, Silva Marques L, Martins de Paiva S, Márcia Pereira S, Vicente Pereira C (2015) Oral physiology and quality of life in cancer patients. Nutr Hosp 31(5):2161–2166. https://doi.org/10.3305/nh.2015.31.5.8565
doi: 10.3305/nh.2015.31.5.8565 pubmed: 25929388
Chen S-C, Huang B-S, Hung T-M, Chang Y-L, Lin C-Y, Chung C-Y et al (2018) Swallowing ability and its impact on dysphagia-specific health-related QOL in oral cavity cancer patients post-treatment. Eur J Oncol Nurs Off J Eur Oncol Nurs Soc 36:89–94
doi: 10.1016/j.ejon.2018.07.002
Hasegawa T, Yatagai N, Furukawa T, Wakui E, Saito I, Takeda D et al (2021) The prospective evaluation and risk factors of dysphagia after surgery in patients with oral cancer. J Otolaryngol 50(1):4
Kao SS-T, Peters MDJ, Krishnan SG, Ooi EH (2016) Swallowing outcomes following primary surgical resection and primary free flap reconstruction for oral and oropharyngeal squamous cell carcinomas: a systematic review. Laryngoscope 126(7):1572–1580
doi: 10.1002/lary.25894 pubmed: 26865034
Ohkoshi A, Ogawa T, Nakanome A, Ishida E, Ishii R, Kato K et al (2018) Predictors of chewing and swallowing disorders after surgery for locally advanced oral cancer with free flap reconstruction: a prospective, observational study. Surg Oncol 27(3):490–494
doi: 10.1016/j.suronc.2018.05.029 pubmed: 30217307
Schulz RE, Bonzanini LIL, Ortigara GB, Soldera EB, Danesi CC, Antoniazzi RP, Ferrazzo KL (2021) Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy. J Appl Oral Sci 29:e20200854. https://doi.org/10.1590/1678-7757-2020-0854
doi: 10.1590/1678-7757-2020-0854 pubmed: 33886946 pmcid: 8075291
Scott B, Butterworth C, Lowe D, Rogers SN (2008) Factors associated with restricted mouth opening and its relationship to health-related quality of life in patients attending a Maxillofacial Oncology clinic. Oral Oncol 44(5):430–438
doi: 10.1016/j.oraloncology.2007.06.015 pubmed: 17826305
Agarwal P, Shiva Kumar HR, Rai KK (2016) Trismus in oral cancer patients undergoing surgery and radiotherapy. J Oral Biol Craniofacial Res 6(Suppl 1):S9-13
doi: 10.1016/j.jobcr.2016.10.004
Kamstra JI, Dijkstra PU, van Leeuwen M, Roodenburg JLN, Langendijk JA (2015) Mouth opening in patients irradiated for head and neck cancer: a prospective repeated measures study. Oral Oncol 51(5):548–555
doi: 10.1016/j.oraloncology.2015.01.016 pubmed: 25703798
Fang F-M, Tsai W-L, Chien C-Y, Chiu H-C, Wang C-J (2004) Health-related quality of life outcome for oral cancer survivors after surgery and postoperative radiotherapy. Jpn J Clin Oncol 34(11):641–646
doi: 10.1093/jjco/hyh118 pubmed: 15613552
Meier JK, Schuderer JG, Zeman F, Klingelhöffer C, Hullmann M, Spanier G et al (2019) Health-related quality of life: a retrospective study on local vs. microvascular reconstruction in patients with oral cancer. BMC Oral Health 19(1):62
doi: 10.1186/s12903-019-0760-2 pubmed: 31029131 pmcid: 6487048
Bower WF, Vlantis AC, Chung TML, Van Hasselt CA (2010) Mode of treatment affects quality of life in head and neck cancer survivors: Implications for holistic care. Acta Otolaryngol (Stockh) 130(10):1185–1192
doi: 10.3109/00016481003667366 pubmed: 20331408
Terrell JE, Ronis DL, Fowler KE, Bradford CR, Chepeha DB, Prince ME et al (2004) Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 130(4):401–408
doi: 10.1001/archotol.130.4.401 pubmed: 15096421
Sharma S, Satyanarayana L, Asthana S, Shivalingesh KK, Goutham BS, Ramachandra S (2018) Oral cancer statistics in India on the basis of first report of 29 population-based cancer registries. J Oral Maxillofac Pathol 22(1):18–26. https://doi.org/10.4103/jomfp.JOMFP_113_17
doi: 10.4103/jomfp.JOMFP_113_17 pubmed: 29731552 pmcid: 5917535
Coelho KR (2012) Challenges of the oral cancer burden in India. J Cancer Epidemiol 2012:701932. https://doi.org/10.1155/2012/701932 . (Epub 2012 Oct 4)
doi: 10.1155/2012/701932 pubmed: 23093961 pmcid: 3471448
Joshi P, Nair S, Chaturvedi P, Nair D, Agarwal JP, D’Cruz AK (2014) Delay in seeking specialized care for oral cancers: experience from a tertiary cancer center. Indian J Cancer 51(2):95–97. https://doi.org/10.4103/0019-509X.137934
doi: 10.4103/0019-509X.137934 pubmed: 25104185
Gupta T, Sinha S, Ghosh-Laskar S, Budrukkar A, Mummudi N, Swain M, Phurailatpam R, Prabhash K, Agarwal JP (2020) Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial. Radiat Oncol 15(1):218. https://doi.org/10.1186/s13014-020-01666-5
doi: 10.1186/s13014-020-01666-5 pubmed: 32938468 pmcid: 7493335
Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A’Hern RP, Sydenham MA, Emson M, Hall E, PARSPORT trial management group (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12(2):127–136. https://doi.org/10.1016/S1470-2045(10)70290-4
doi: 10.1016/S1470-2045(10)70290-4 pubmed: 21236730 pmcid: 3033533
Thaduri A, Garg PK, Malhotra M, Singh MP, Poonia DR, Priya M, Tyagi A, Kumar A, Bhardwaj A, Jat B, Panuganti A, Majumdar K, Usmani S, Singh V (2023) Financial toxicity and mental well-being of the oral cancer survivors residing in a developing country in the era of COVID 19 pandemic—a cross-sectional study. Psychooncology 32(1):58–67. https://doi.org/10.1002/pon.6030 . (Epub 2022 Sep 14)
doi: 10.1002/pon.6030 pubmed: 36073555
Sittitrai P, Ruenmarkkaew D, Klibngern H (2022) Pedicled flaps versus free flaps for oral cavity cancer reconstruction: a comparison of complications, hospital costs, and functional outcomes. Int Arch Otorhinolaryngol 27(1):e32–e42. https://doi.org/10.1055/s-0042-1751001
doi: 10.1055/s-0042-1751001 pubmed: 36714904 pmcid: 9879635

Auteurs

Abhinav Thaduri (A)

Department of ENT, Prathima Relief Medical College, Warangal, India. abhinavthadurient@gmail.com.
Head and Neck Services, Prathima Cancer Institute, Warangal, India. abhinavthadurient@gmail.com.

Sravani Reddy Kappari (SR)

Department of ENT, Kamineni Academy of Medical Sciences and Research Centre, Hyderabad, India.

Kinjal Shankar Majumdar (KS)

Division of Head and Neck Surgery, Kasturba Medical College, Manipal, India.

Achyuth Panuganti (A)

Department of ENT, Mediciti Institute of Medical Sciences, Hyderabad, India.

Shahab Ali Usmani (SA)

Remedy Comprehensive Cancer Centre, Lucknow, India.

Vikramjit Singh (V)

Department of ENT&Head and Neck Surgery, AIIMS, Rishikesh, India.

Areej Moideen (A)

Department of ENT&Head and Neck Surgery, AIIMS, Rishikesh, India.

Manu Malhotra (M)

Department of ENT&Head and Neck Surgery, AIIMS, Rishikesh, India.

Pankaj Kumar Garg (PK)

Department of Surgical Oncology, Shri Guru Ram Rai Institute of Medical and Health Science, Dehradun, India.

Classifications MeSH